Your browser doesn't support javascript.
loading
Systematic review and Meta-analysis of safety of Sanfu acupoint herbal patching in randomized controlled trial / 中国中药杂志
China Journal of Chinese Materia Medica ; (24): 1276-1283, 2021.
Article Dans Chinois | WPRIM | ID: wpr-879030
ABSTRACT
In order to systematically evaluate the safety of Sanfu acupoint herbal patching, CNKI, SinoMed, VIP, Wanfang, PubMed, Medline, EMbase, and Cochrane Library were searched in accordance with PICOS principles, with a time limit from database establishment to December 2019. Meta-analysis was used for a single-group rate analysis and a weighted combination of these two groups on rates of adverse reactions. A total of 9 articles meeting the inclusion criteria were included in the analysis, involving 2 119 patients. The single-group rate Meta-analysis showed that the adverse reactions incidence was 9% in the treatment group(OR=0.10,95%CI[0.06, 0.19], P<0.000 01), and 9% in the control group(OR=0.10, 95%CI[0.07, 0.13], P<0.000 01). In combined statistics of all samples OR=1.81, 95%CI[1.04, 3.15], P=0.04, the incidence of adverse reactions in the treatment group was slightly higher than that of the control group. In the subgroup analysis, the incidence of adverse reactions in terms of both single-group rate and weighed rate in the treatment group was higher than that in the control group in the asthma subgroup, rhinitis subgroup, ≥18 years old subgroup, and application time 2 h subgroup, with statistically significant differences(P<0.05). The results of the Meta-analysis and systematic review suggested that the incidence of adverse reactions in clinical use of the Sanfu acupoints herbal patching was relatively low. The main types of adverse reactions were skin ulcers, blisters and other skin symptoms. The symptoms were relatively mild, which could be relieved by drug withdrawal or symptomatic treatment. It shows that the safety of the Sanfu acupoint herbal patching was relatively high, and the occurrence of adverse reactions was related to the original disease and age, mainly in asthma and rhinitis or patients over 40 years old. Affected by clinical heterogeneity, the conclusions of the application time subgroup need to be further improved.
Sujets)

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Sujet Principal: Asthme / Médicaments issus de plantes chinoises / Points d&apos;acupuncture / Essais contrôlés randomisés comme sujet / Incidence / Bases de données factuelles Type d'étude: Essai clinique contrôlé / Etude d'incidence / Étude pronostique / Revues systématiques évaluées Limites du sujet: Adolescent / Adulte / Humains langue: Chinois Texte intégral: China Journal of Chinese Materia Medica Année: 2021 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Sujet Principal: Asthme / Médicaments issus de plantes chinoises / Points d&apos;acupuncture / Essais contrôlés randomisés comme sujet / Incidence / Bases de données factuelles Type d'étude: Essai clinique contrôlé / Etude d'incidence / Étude pronostique / Revues systématiques évaluées Limites du sujet: Adolescent / Adulte / Humains langue: Chinois Texte intégral: China Journal of Chinese Materia Medica Année: 2021 Type: Article